Michael A. Mussallem, Chairman & CEO at Edwards Lifesciences Corp (EW), sold 49,250 shares at $84.10 ($3.3M) on 2023-04-14, disclosed to the SEC on 2023-04-17.
Scheduled sale ($3.3M) by Chairman & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,500 | $0 | 0.0% |
| 2 | $84.10 | 16,059 | $1.4M | 40.4% |
| 3 | $84.10 | 16,059 | $1.4M | 40.4% |
| 4 | $84.61 | 3,816 | $323K | 9.6% |
| 5 | $84.61 | 3,816 | $323K | 9.6% |
| Total | $67.96 avg | 49,250 |
| $3.3M |
| 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |